All In Biotech

Drug Trial Radar · NCT00111163

Intermittent Preventive Treatment With Antimalarials in Kenyan Infants

Efficacy and Safety of Pediatric Immunization-linked Preventive Intermittent Treatment With Antimalarials in Decreasing Anemia and Malaria Morbidity in Rural Western Kenya

Last checked: Nov 19, 2026Latest source record: Sep 27, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,516 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,516

Actual

Start

Mar 2004

Primary completion

Mar 2006

Study completion Mar 2008

Sponsor

Sponsor type
Federal agency
Collaborators
Kenya Medical Research Institute; Bill and Melinda Gates Foundation
First posted
May 18, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Single group
Masking
Double
Primary purpose
Prevention
Who can join
All sexes, from 5 weeks, up to 16 weeks
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the study is to see whether antimalarial drugs administered at the time of routine infant vaccinations prevents malaria and anemia in the first year of life.

Conditions

  • Malaria
  • Anemia

Interventions

  • sulfadoxine-pyrimethamine with artesunateDrug

  • amodiaquine with artesunateDrug

  • chlorproguanil-dapsoneDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical malaria in the first year of life

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Lwak, Abidha, Ongielo and Saradidi clinics

    Asembo (Rarieda Division), Nyanza Province, Kenya

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.